Haleon PLC (HLN)
8.30
-0.02
(-0.24%)
USD |
NYSE |
May 03, 16:00
8.295
0.00 (0.00%)
After-Hours: 20:00
Haleon Price to Book Value: 1.792 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.792 |
| May 02, 2024 | 1.796 |
| May 01, 2024 | 1.802 |
| April 30, 2024 | 1.841 |
| April 29, 2024 | 1.828 |
| April 26, 2024 | 1.824 |
| April 25, 2024 | 1.813 |
| April 24, 2024 | 1.802 |
| April 23, 2024 | 1.815 |
| April 22, 2024 | 1.804 |
| April 19, 2024 | 1.774 |
| April 18, 2024 | 1.755 |
| April 17, 2024 | 1.750 |
| April 16, 2024 | 1.748 |
| April 15, 2024 | 1.740 |
| April 12, 2024 | 1.729 |
| April 11, 2024 | 1.764 |
| April 10, 2024 | 1.764 |
| April 09, 2024 | 1.789 |
| April 08, 2024 | 1.774 |
| April 05, 2024 | 1.789 |
| April 04, 2024 | 1.776 |
| April 03, 2024 | 1.779 |
| April 02, 2024 | 1.787 |
| April 01, 2024 | 1.800 |
| Date | Value |
|---|---|
| March 31, 2024 | |
| March 28, 2024 | 1.833 |
| March 27, 2024 | 1.841 |
| March 26, 2024 | 1.815 |
| March 25, 2024 | 1.820 |
| March 22, 2024 | 1.809 |
| March 21, 2024 | 1.798 |
| March 20, 2024 | 1.798 |
| March 19, 2024 | 1.829 |
| March 18, 2024 | 1.772 |
| March 15, 2024 | 1.814 |
| March 14, 2024 | 1.796 |
| March 13, 2024 | 1.875 |
| March 12, 2024 | 1.890 |
| March 11, 2024 | 1.868 |
| March 08, 2024 | 1.884 |
| March 07, 2024 | 1.866 |
| March 06, 2024 | 1.818 |
| March 05, 2024 | 1.818 |
| March 04, 2024 | 1.814 |
| March 01, 2024 | 1.844 |
| February 29, 2024 | 1.868 |
| February 28, 2024 | 1.759 |
| February 27, 2024 | 1.798 |
| February 26, 2024 | 1.805 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7969
Minimum
Sep 02 2022
2.103
Maximum
Apr 20 2023
1.627
Average
1.823
Median
Jul 03 2023
Price to Book Value Benchmarks
| Pfizer Inc | 1.769 |
| GSK PLC | 5.076 |
| AstraZeneca PLC | 6.322 |
| Verona Pharma PLC | 5.087 |
| Adaptimmune Therapeutics PLC | 7.434 |
Price to Book Value Related Metrics
| PE Ratio | 27.96 |
| PS Ratio | 2.714 |
| PEG Ratio | 8.883 |
| Price | 8.30 |
| Earnings Yield | 3.58% |
| Market Cap | 37.90B |
| PEGY Ratio | 5.610 |
| Operating PE Ratio | 15.03 |
| Normalized PE Ratio | 28.15 |